Ido Wolf

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 12

Top Topics

Transition Metal

Neuroendocrine Tumors

Ejection Fraction

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Esther Osher, Eiman Shalabna, Joseph M Klausner, Yona Greenman, Naftali Stern, Oren Shibolet, Erez Scapa, Oz Yakir, Dana Ben-Ami Shor, Iddo Bar-Yishay, Sivan Shamai, Yael Sofer, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Ido Wolf, Sharon Pelles, Asaf Aizic, Arye Blachar, Ravit Geva
A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors. Biomedicines 11 (2) (2023)
Esther Osher, Eiman Shalabna, Joseph M Klausner, Yona Greenman, Naftali Stern, Oren Shibolet, Erez Scapa, Oz Yakir, Dana Ben-Ami Shor, Iddo Bar-Yishay, Sivan Shamai, Yael Sofer, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Ido Wolf, Sharon Pelles, Asaf Aizic, Arye Blachar, Ravit Geva
A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors. Biomedicines 11 (2) (2023)
Omer Goldman, Lital N Adler, Emma Hajaj, Tommaso Croese, Naama Darzi, Sivan Galai, Hila Tishler, Yarden Ariav, Dor Lavie, Liat Fellus-Alyagor, Roni Oren, Yuri Kuznetsov, Eyal David, Rami Jaschek, Chani Stossel, Oded Singer, Sergey Malitsky, Renana Barak, Rony Seger, Neta Erez, Bjørt K Kragesteen, Amos Tanay, Ann Saada, Talia Golan, Tamar Rubinek, Joo Sang Lee, Shay Ben-Shachar, Ido Wolf, Ayelet Erez
Early infiltration of innate immune cells to the liver depletes HNF4a and promotes extra-hepatic carcinogenesis. Cancer discovery (2023)
Daniel Keizman, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid, Ilan Leibovitch, Roy Mano, Ofer Yossepowitch, Ido Wolf, Ravit Geva, David Margel, Keren Rouvinov, Anat Stern, Hadas Dresler, Igal Kushnir, Isaac Eliaz
Modified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study. Nutrients 15 (16) (2023)
Esther Osher, Eiman Shalabna, Joseph M Klausner, Yona Greenman, Naftali Stern, Oren Shibolet, Erez Scapa, Oz Yakir, Dana Ben-Ami Shor, Iddo Bar-Yishay, Sivan Shamai, Yael Sofer, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Ido Wolf, Sharon Pelles, Asaf Aizic, Arye Blachar, Ravit Geva
A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors. Biomedicines 11 (2) (2023)
Yossi Maman, Yaacov Goykhman, Oz Yakir, Alex Barenboim, Ravit Geva, Sharon Peles-Avraham, Ido Wolf, Joseph M Klausner, Guy Lahat, Nir Lubezky
Adjuvant FOLFIRINOX in Patients with Resectable Pancreatic Cancer Is Effective but Rarely Feasible in Real Life: Is Neoadjuvant FOLFIRINOX a Better Option? Cancers 15 (11) (2023)
Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 15 (1) (2022)
Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 15 (1) (2022)
Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 15 (1) (2022)
Shira Peleg Hasson, Dov Hershkovitz, Lyri Adar, Miriam Brezis, Eliya Shachar, Rona Aks, Lee Galmor, Yuval Raviv, Shira Ben Neriah, Ofer Merimsky, Edmond Sabo, Ido Wolf, Tamar Safra
Implementation of Comprehensive Genomic Profiling in Ovarian Cancer Patients: A Retrospective Analysis. Cancers 15 (1) (2022)
Tamar Safra, Barliz Waissengrin, Talya Levy, Ellie Leidner, Rotem Merose, Diana Matceyevsky, Dan Grisaru, Ido Laskov, Nadav Mishaan, Rotem Shayzaf, Ido Wolf
Weekly Carboplatin and Paclitaxel: A Retrospective Comparison with the Three-Weekly Schedule in First-Line Treatment of Ovarian Cancer. The oncologist 26 (1) (2020)
Tomer Boldes, Keren Merenbakh-Lamin, Shani Journo, Eliya Shachar, Doron Lipson, Adva Yeheskel, Metsada Pasmanik-Chor, Tami Rubinek, Ido Wolf
R269C variant of ESR1: high prevalence and differential function in a subset of pancreatic cancers. BMC cancer 20 (1) (2020)